HomeCompareSPRAX vs DIVO

SPRAX vs DIVO: Dividend Comparison 2026

SPRAX yields 1.11% · DIVO yields 6.62%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $9.7K in total portfolio value
10 years
SPRAX
SPRAX
● Live price
1.11%
Share price
$27.64
Annual div
$0.31
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.3K
Annual income
$119.21
Full SPRAX calculator →
DIVO
DIVO
● Live price
6.62%
Share price
$44.00
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$31.0K
Annual income
$1,008.47
Full DIVO calculator →

Portfolio growth — SPRAX vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPRAXDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPRAX + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPRAX pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPRAX
Annual income on $10K today (after 15% tax)
$94.29/yr
After 10yr DRIP, annual income (after tax)
$101.33/yr
DIVO
Annual income on $10K today (after 15% tax)
$562.67/yr
After 10yr DRIP, annual income (after tax)
$857.20/yr
At 15% tax rate, DIVO beats the other by $755.87/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPRAX + DIVO for your $10,000?

SPRAX: 50%DIVO: 50%
100% DIVO50/50100% SPRAX
Portfolio after 10yr
$26.1K
Annual income
$563.84/yr
Blended yield
2.16%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPRAX buys
0
DIVO buys
0
No recent congressional trades found for SPRAX or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPRAXDIVO
Forward yield1.11%6.62%
Annual dividend / share$0.31$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$21.3K$31.0K
Annual income after 10y$119.21$1,008.47
Total dividends collected$1.2K$8.4K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SPRAX vs DIVO ($10,000, DRIP)

YearSPRAX PortfolioSPRAX Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$10,811$110.93$11,362$661.96$551.00DIVO
2$11,680$112.08$12,860$702.91$1.2KDIVO
3$12,611$113.17$14,504$743.56$1.9KDIVO
4$13,607$114.19$16,303$783.73$2.7KDIVO
5$14,675$115.16$18,268$823.31$3.6KDIVO
6$15,818$116.07$20,408$862.17$4.6KDIVO
7$17,043$116.93$22,737$900.20$5.7KDIVO
8$18,353$117.73$25,266$937.31$6.9KDIVO
9$19,757$118.49$28,008$973.42$8.3KDIVO
10$21,259$119.21$30,977$1,008.47$9.7KDIVO

SPRAX vs DIVO: Complete Analysis 2026

SPRAXStock

The fund normally invests at least 80% of its investable assets in equity and equity-related securities of mid-cap companies. The sub-adviser considers mid-cap companies to be companies with market capitalizations within the market cap range of companies included in the Russell Midcap Index (measured at the time of purchase). Most of the fund's assets will typically be invested in U.S. equity and equity-related securities, including up to 25% of its total assets in real estate investment trusts ("REITs").

Full SPRAX Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SPRAX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPRAX vs SCHDSPRAX vs JEPISPRAX vs OSPRAX vs KOSPRAX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.